Fig 1: Western blot analyses of GAB2, CRKL and FRS2 expression in PDAC and matched normal tissues. T: PDAC tissue; N: peritumor normal tissue. ß-actin was used as a loading control
Fig 2: Kaplan-Meier curves of DFS and OS with different expression patterns of GAB2, CRKL, and FRS2. DFS according to GAB2 expression pattern (P = 0.005) (a) CRKL expression pattern (P = 0.036) (b) FRS2 expression pattern (P = 0.037) (c) and GAB2/CRKL/FRS2 co-expression pattern (P = 0.015) (d). OS according to GAB2 expression pattern (P = 0.031) (e) CRKL expression pattern (P = 0.020) (f), FRS2 expression pattern (P = 0.003) (g) and GAB2/CRKL/FRS2 co-expression pattern (P = 0.001) (h)
Fig 3: Expression of GAB2, CRKL and FRS2: GAB-/+ expression (a) CRKL-/+ expression (b) FRS2-/+ expression (c). Magnification × 100
Fig 4: Correlations between GAB2 and CRKL expression, GAB2 and FRS2 expression, and CRKL and FRS2 expression in PDAC: GAB2 expression correlated with CRKL (r = 0.3742, P = 0.001) (a) GAB2 expression correlated with FRS2 (r = 0.5241, P < 0.001) (b) CRKL expression correlated with FRS2 (r = 0.2945, P = 0.0098) (c)
Supplier Page from Abcam for Anti-GAB2 antibody [EPR2869]